LakeShore Biopharma Co., Ltd. (LSBCF) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -99.98M CNY | +76.9% |
| 2024 | -433.46M CNY | -198.0% |
| 2023 | -145.48M CNY | -37.2% |
| 2022 | -106.00M CNY | +44.7% |
| 2021 | -191.83M CNY | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -99.98M CNY | +76.9% |
| 2024 | -433.46M CNY | -198.0% |
| 2023 | -145.48M CNY | -37.2% |
| 2022 | -106.00M CNY | +44.7% |
| 2021 | -191.83M CNY | — |